30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Cerapedics Closes $22MM Financing -

Cerapedics completed a US $22MM financing. Proceeds will support continued launch of i-FACTOR™ Peptide Enhanced Bone Graft and a second Level I investigational device exemption (IDE) human clinical study. (Cerapedics, 7/16/18)